Search

Your search keyword '"Alberto Alvarado-Miranda"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Alberto Alvarado-Miranda" Remove constraint Author: "Alberto Alvarado-Miranda" Language undetermined Remove constraint Language: undetermined
37 results on '"Alberto Alvarado-Miranda"'

Search Results

1. Pathogenic variant profile in DNA damage response genes correlates with metastatic breast cancer progression-free survival in a Mexican-mestizo population

2. Risk factors for the development of hematological toxicity during the application of weekly paclitaxel in breast cancer

Catalog

Books, media, physical & digital resources

3. Identification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptoms

4. Prognosis of breast cancer diagnosed during pregnancy and early postpartum according to immunohistochemical subtype: A matched case–control study

5. Abstract P1-19-07: Real-world characteristics, treatment patterns, and overall survival in patients with metastatic breast cancer (mBC) and CNS metastases

6. Clinical characteristics and outcomes of older women with breast cancer in Mexico

7. Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy

8. Real-World Outcomes Among Older Mexican Women with Breast Cancer Treated with Neoadjuvant Chemotherapy

9. Abstract P2-11-10: Effect of supplementation with eicosapentaenoic and docosahexaenoic omega-3 polyunsaturated fatty acid on the chemotoxicity in Mexican patients with locally advanced breast cancer (LABC) treated with neoadjuvant chemotherapy (NeoCT)

10. 216P The impact of pregnancy-associated breast cancer (PABC) according to immunohistochemical (IHC) subtype: A matched case-control study

11. Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment

12. miRNA profile obtained by next‑generation sequencing in metastatic breast cancer patients is able to predict the response to systemic treatments

13. Factores de riesgo para el desarrollo de toxicidad hematológica durante la aplicación de paclitaxel semanal en cáncer de mama

14. Effects of omega-3 fatty acids supplementation on neoadjuvant chemotherapy-induced toxicity in patients with locally advanced breast cancer: a randomized, controlled, double-blinded clinical trial

15. Outcomes of Hispanic women with lymph-node positive, HER2 positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab in Mexico

16. Clinical and Epidemiological Profile of Breast Cancer in Mexico: Results of the Seguro Popular

17. A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer

18. Molecular Subtypes and Prognosis in Young Mexican Women With Breast Cancer

19. Clinical Features and Prognostic Factors in Patients with Carcinomatous Meningitis Secondary to Breast Cancer

20. Clinicopathological features and prognosis of pregnancy associated breast cancer at Instituto Nacional de Cancerología of Mexico

21. Real-world outcomes in young women with breast cancer treated with neoadjuvant chemotherapy

22. Factores pronósticos en pacientes con cáncer de mama y metástasis cerebral como primer sitio de recurrencia

23. Neutrophil/lymphocyte ratio as a predictive value for overall survival in locally advanced breast cancer patients receiving neoadjuvant chemotherapy at the National Cancer Institute of Mexico

24. [Evaluation of breast cancer treatment at a tertiary-level institution with Popular Health Insurance in Mexico]

25. Clinical features and prognostic factors in patients with carcinomatous meningitis secondary to breast cancer

26. Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer

27. Randomized phase II trial to evaluate the safety and efficacy of neoadjuvant cisplatin in combination with taxanes-anthracyclines vs taxanes-anthracyclines alone in locally advanced triple negative breast cancer

28. Outcome of neoadjuvant-treated young patients with hormone receptor-positive breast cancer

29. Meetings and Conferences · Tagungen und Kongresse

30. Ocular metastases from breast carcinoma

31. Impact of chemotherapy dose intensity in the geriatric population with locally advanced breast cancer treated in neoadjuvant setting at the National Cancer Institute, Mexico City

32. Combination treatment with aromatase inhibitor and capecitabine as first- or second-line treatment in metastatic breast cancer

33. Impact of diabetes and hyperglycemia on outcomes in advanced breast cancer patients

34. Impact of obesity and overweight in the prognosis of women diagnosed with non metastatic breast cancer in a Mexican cohort

35. Contents of Forthcoming Issues · Themenvorschau

36. Concurrent chemoradiotherapy (CRT) following neoadjuvant chemotherapy (NACT) in locally advanced breast cancer (LABC)

37. Intermittent adjuvant chemotherapy as an alternative to improve survival in breast cancer patients with ten or more positive lymph nodes